Yahoo Web Search

Search results

    • Novavax Reports First Quarter 2024 Financial Results and Operational Highlights

      WKBN 27 Youngstown· 7 days ago

      ...Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a potential multi-billion dollar revenue opportunity for Novavax including:$500 million upfront...